202 related articles for article (PubMed ID: 25187080)
1. [Genetic basis of seborrheic keratosis and epidermal nevi].
Hafner C; Hafner H; Groesser L
Pathologe; 2014 Sep; 35(5):413-23. PubMed ID: 25187080
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.
Hafner C; López-Knowles E; Luis NM; Toll A; Baselga E; Fernández-Casado A; Hernández S; Ribé A; Mentzel T; Stoehr R; Hofstaedter F; Landthaler M; Vogt T; Pujol RM; Hartmann A; Real FX
Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13450-4. PubMed ID: 17673550
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis.
Georgieva IA; Mauerer A; Groesser L; Herschberger E; Aslanidis C; Dietmaier W; Landthaler M; Hafner C
Am J Dermatopathol; 2014 Aug; 36(8):635-42. PubMed ID: 23739246
[TBL] [Abstract][Full Text] [Related]
4. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors.
Hafner C; Toll A; Fernández-Casado A; Earl J; Marqués M; Acquadro F; Méndez-Pertuz M; Urioste M; Malats N; Burns JE; Knowles MA; Cigudosa JC; Hartmann A; Vogt T; Landthaler M; Pujol RM; Real FX
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20780-5. PubMed ID: 21078999
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.
Hernández S; Toll A; Baselga E; Ribé A; Azua-Romeo J; Pujol RM; Real FX
J Invest Dermatol; 2007 Jul; 127(7):1664-6. PubMed ID: 17255960
[TBL] [Abstract][Full Text] [Related]
6. FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin.
Hafner C; Hartmann A; Vogt T
J Invest Dermatol; 2007 Jul; 127(7):1572-3. PubMed ID: 17568799
[TBL] [Abstract][Full Text] [Related]
7. Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C; Vogt T; Landthaler M; Müsebeck J
Br J Dermatol; 2008 Jul; 159(1):214-7. PubMed ID: 18503601
[TBL] [Abstract][Full Text] [Related]
8. Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi.
Hafner C; van Oers JM; Vogt T; Landthaler M; Stoehr R; Blaszyk H; Hofstaedter F; Zwarthoff EC; Hartmann A
J Clin Invest; 2006 Aug; 116(8):2201-2207. PubMed ID: 16841094
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in seborrheic keratoses.
Heidenreich B; Denisova E; Rachakonda S; Sanmartin O; Dereani T; Hosen I; Nagore E; Kumar R
Oncotarget; 2017 May; 8(22):36639-36649. PubMed ID: 28410231
[TBL] [Abstract][Full Text] [Related]
10. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Logié A; Dunois-Lardé C; Rosty C; Levrel O; Blanche M; Ribeiro A; Gasc JM; Jorcano J; Werner S; Sastre-Garau X; Thiery JP; Radvanyi F
Hum Mol Genet; 2005 May; 14(9):1153-60. PubMed ID: 15772091
[TBL] [Abstract][Full Text] [Related]
11. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
[TBL] [Abstract][Full Text] [Related]
12. FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localization.
Hafner C; Hartmann A; van Oers JM; Stoehr R; Zwarthoff EC; Hofstaedter F; Landthaler M; Vogt T
Mod Pathol; 2007 Aug; 20(8):895-903. PubMed ID: 17585316
[TBL] [Abstract][Full Text] [Related]
13. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors.
Duperret EK; Oh SJ; McNeal A; Prouty SM; Ridky TW
Cell Cycle; 2014; 13(10):1551-9. PubMed ID: 24626198
[TBL] [Abstract][Full Text] [Related]
14. [Multiple oncogenic mutations in seborrheic keratoses].
Berneburg M
Hautarzt; 2011 Jan; 62(1):63-4. PubMed ID: 21206987
[No Abstract] [Full Text] [Related]
15. Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours.
Hida Y; Kubo Y; Arase S
Br J Dermatol; 2009 Jun; 160(6):1258-63. PubMed ID: 19298285
[TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical mosaicism in a type of epidermal nevus.
Paller AS; Syder AJ; Chan YM; Yu QC; Hutton E; Tadini G; Fuchs E
N Engl J Med; 1994 Nov; 331(21):1408-15. PubMed ID: 7526210
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 and PIK3CA mutations in stucco keratosis and dermatosis papulosa nigra.
Hafner C; Landthaler M; Mentzel T; Vogt T
Br J Dermatol; 2010 Mar; 162(3):508-12. PubMed ID: 19845664
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses.
Hafner C; Hartmann A; Real FX; Hofstaedter F; Landthaler M; Vogt T
J Invest Dermatol; 2007 Aug; 127(8):1883-5. PubMed ID: 17392824
[TBL] [Abstract][Full Text] [Related]
19. What is a nevus? A proposed definition of a common medical term.
Happle R
Dermatology; 1995; 191(1):1-5. PubMed ID: 8589475
[TBL] [Abstract][Full Text] [Related]
20. FGFR3 mutations in benign skin tumors.
Hafner C; Vogt T; Hartmann A
Cell Cycle; 2006 Dec; 5(23):2723-8. PubMed ID: 17172848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
